ABHD14A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.583950E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.160800E-01
Normal-vs-Stage2
6.869000E-01
Normal-vs-Stage3
7.778200E-01
Normal-vs-Stage4
8.392200E-01
Stage1-vs-Stage2
3.389200E-01
Stage1-vs-Stage3
3.010600E-01
Stage1-vs-Stage4
3.405000E-01
Stage2-vs-Stage3
3.924200E-01
Stage2-vs-Stage4
9.224800E-01
Stage3-vs-Stage4
6.875000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.104330E-02
Normal-vs-AfricanAmerican
2.080000E-01
Normal-vs-Asian
5.302200E-01
Caucasian-vs-AfricanAmerican
2.413000E-04
Caucasian-vs-Asian
3.465800E-01
AfricanAmerican-vs-Asian
5.146200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.730300E-02
Normal-vs-Female
6.822400E-02
Male-vs-Female
8.558400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.178800E-01
Normal-vs-Age(41-60Yrs)
6.910600E-01
Normal-vs-Age(61-80Yrs)
2.278400E-02
Normal-vs-Age(81-100Yrs)
4.364800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.350800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.505600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.374000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.100200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.854600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.301400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.874800E-01
Normal-vs-Daily Drinker
4.248300E-02
Normal-vs-Weekly Drinker
3.719000E-01
Normal-vs-Occasional Drinker
1.838960E-01
Normal-vs-Social Drinker
4.716400E-01
Non Drinker-vs-Daily Drinker
8.108400E-02
Non Drinker-vs-Weekly Drinker
2.486800E-01
Non Drinker-vs-Occasional Drinker
2.368400E-01
Non Drinker-vs-Social Drinker
2.975600E-01
Daily Drinker-vs-Weekly Drinker
3.491000E-01
Daily Drinker-vs-Occasional Drinker
7.432600E-01
Daily Drinker-vs-Social Drinker
3.484800E-01
Weekly Drinker-vs-Occasional Drinker
4.164200E-01
Weekly Drinker-vs-Social Drinker
9.571200E-01
Occasional Drinker-vs-Social Drinker
4.093800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.716600E-01
Normal-vs-Grade 2
3.100000E-01
Normal-vs-Grade 3
4.415600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.865800E-02
Grade 1-vs-Grade 3
2.028100E-02
Grade 1-vs-Grade 4
4.716600E-01
Grade 2-vs-Grade 3
8.302300E-02
Grade 2-vs-Grade 4
3.100000E-01
Grade 3-vs-Grade 4
4.415600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.330800E-01
Normal-vs-NonDiabetic
1.181830E-02
Diabetic-vs-NonDiabetic
1.736960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.150400E-01
Normal-vs-NoPancreatitis
1.140160E-02
Pancreatitis-vs-NoPancreatitis
4.659800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.075800E-02
Normal-vs-N1
6.457600E-01
N0-vs-N1
9.323600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.355800E-01
Normal-vs-TP53-NonMutant
1.802530E-03
TP53-Mutant-vs-TP53-NonMutant
2.357300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
